Keyphrases
25Mg
16%
Acute Changes
33%
Bacterial Pathogens
22%
Brensocatib
66%
Cancer Development
33%
Chronic Lung Inflammation
11%
Clinical Outcomes
16%
Clinical Status
26%
Community-acquired Pneumonia
33%
COVID-19
100%
COVID-19 Infection
16%
COVID-19 Pandemic
33%
Dipeptidyl Peptidase 1
66%
Dundee
11%
Fatal COVID-19
16%
Hospitalized Patients
71%
Inclusion Criteria
16%
Lung Cancer Risk
22%
Lymphocyte Count
16%
Malignancy
11%
Neutrophil Elastase
23%
Neutrophilic Inflammation
33%
Neutrophils
33%
Once-daily
11%
Oral Inhibitors
16%
Oxygen Saturation
16%
Patients with Cancer
22%
Patients with COVID-19
33%
Placebo
23%
Placebo Groups
20%
Placebo-controlled Trial
33%
Pneumonia
22%
Poor Prognosis
11%
Proteome
33%
Pulmonary Involvement
16%
Randomized Placebo-controlled Trial
66%
Respiratory Cancer
33%
Respiratory Infection
33%
Respiratory Pathogens
11%
Risk Factors
31%
Room Air
16%
SARS-CoV-2 Infection
25%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
33%
Severe Disease
29%
SFX-01
33%
Streptococcus Pneumoniae
11%
Sulforaphane
16%
Supplemental Oxygen
16%
Sustained Change
33%
UK Hospitals
16%
Medicine and Dentistry
Adverse Event
6%
Anti-Inflammatory Drug
8%
Antioxidant
8%
Blood Pressure
8%
Cancer
8%
Chronic Obstructive Pulmonary Disease
8%
Community-Acquired Pneumonia
33%
COVID-19
100%
Dipeptidyl Peptidase
66%
Disease
22%
Infection
42%
Intention-to-Treat Analysis
6%
Lung
8%
Lung Cancer
33%
Lymphocyte
11%
Malignant Neoplasm
25%
Microbiome
8%
Neutrophil
17%
Oxygen Saturation
11%
Pathogen
33%
Physical Examination
11%
Placebo
100%
Pneumococcus
8%
Pneumonia
8%
Respiratory Tract Infection
33%
Septic Shock
8%
Serine Proteinase
21%
Serositis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Sulforaphane
16%
Transcription Factor Nrf2
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
6%
Anti-Inflammatory Drug
8%
Antioxidant
8%
Chronic Obstructive Lung Disease
6%
Community Acquired Pneumonia
33%
Dipeptidyl Peptidase
66%
Disease
21%
Infection
40%
Infectious Agent
26%
Inflammation
38%
Lung Cancer
33%
Malignant Neoplasm
33%
Microbiome
6%
Pandemic
33%
Placebo
100%
Pneumonia
6%
Respiratory Tract Infection
33%
SARS Coronavirus
19%
Septic Shock
6%
Serine Proteinase
21%
Streptococcus
6%
Sulforaphane
16%
Transcription Factor Nrf2
16%
